PharmaShots | Incisive News in 3 Shots

Subscribe Now

Approve

The US FDA Declines to Approve Incyte's Retifanlimab to Treat Patients with Squamous Cell Carcinoma of the Anal Canal

The US FDA Declines to Approve Incyte's Retifanlimab to Treat Patients with Squamous Cell Carcinoma of the Anal Canal

July 26, 2021

Regeneron Seeks the US FDA's EUA for REGN-COV2 Antibody Combination to Treat COVID-19

Regeneron Seeks the US FDA's EUA for REGN-COV2 Antibody Combination to Treat COVID-19

October 9, 2020

The US FDA will Approve a New Pathway for Biosimilars

The US FDA will Approve a New Pathway for Biosimilars

March 23, 2020

Contact Us

First Floor, B-66, Sector 63 Noida, Uttar Pradesh, INDIA - 201301
+91-120 428 0707
connect@pharmashots.com
Newsletter

Our Information

Follow Us